Katharine Harding

2.7k total citations · 1 hit paper
47 papers, 1.3k citations indexed

About

Katharine Harding is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Katharine Harding has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 16 papers in Rheumatology and 7 papers in Neurology. Recurrent topics in Katharine Harding's work include Multiple Sclerosis Research Studies (32 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Sclerosis and Related Diseases (10 papers). Katharine Harding is often cited by papers focused on Multiple Sclerosis Research Studies (32 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Systemic Sclerosis and Related Diseases (10 papers). Katharine Harding collaborates with scholars based in United Kingdom, Canada and Australia. Katharine Harding's co-authors include Neil P. Robertson, Trevor Pickersgill, Mark Wardle, Emma Tallantyre, Fady Joseph, Valentina Tomassini, Mark Willis, Claire Hirst, Owain Williams and Yoav Ben‐Shlomo and has published in prestigious journals such as Neurology, Annals of Neurology and Journal of Clinical Epidemiology.

In The Last Decade

Katharine Harding

44 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

2019 227 citations Katharine Harding, Owain Williams et al. profile →

Peers

Countries citing papers authored by Katharine Harding

Since Specialization

Citations

This map shows the geographic impact of Katharine Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine Harding more than expected).

Fields of papers citing papers by Katharine Harding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine Harding. The network helps show where Katharine Harding may publish in the future.

Co-authorship network of co-authors of Katharine Harding

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine Harding. A scholar is included among the top collaborators of Katharine Harding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine Harding. Katharine Harding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort 2024 ·Neuroepidemiology ·(unknown), Katharine Harding, James Hrastelj, Karim L. Kreft, Peter Holmans, Neil P. Robertson, Emma Tallantyre, Michael Lawton	2
2	Prodromal multiple sclerosis: considerations and future utility 2024 ·Journal of Neurology ·Katharine Harding, Karim L. Kreft, Yoav Ben‐Shlomo, Neil P. Robertson	4
3	Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study 2023 ·Journal of Neurology ·Lance Watkins, (unknown), Crispin Musicha, Charlotte Lawthom, Kristen St. John, Chloe J. Bright, (unknown), Katharine Harding, S.Y. Moon, Sarah E. Pape, (unknown), Victoria Allgar, Rhys H. Thomas, Brendan McLean, Richard Laugharne, Rohit Shankar	5
4	Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study 2023 ·Neurological Sciences ·Αθανάσιος Παπαθανασίου, (unknown), Emma Tallantyre, Katharine Harding, (unknown), Matt Morgan, (unknown), (unknown), Tarunya Arun, Gillian Ingram, Graham Law, Nikos Evangelou	6
5	Contemporary study of multiple sclerosis disability in South East Wales 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·Katharine Harding, Gillian Ingram, Emma Tallantyre, Fady Joseph, Mark Wardle, Trevor Pickersgill, Mark Willis, Valentina Tomassini, Owen Pearson, Neil P. Robertson	4
6	Exploring seizure management in hospitals, unmet need, and the impact of the COVID-19 pandemic on seizure presentations to hospital 2022 ·Seizure ·(unknown), (unknown), (unknown), (unknown), (unknown), Charlotte Lawthom, Katharine Harding, Joseph C. Anderson	0
7	120 UK multiple sclerosis registries project: disease modifying treatment durability 2022 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), (unknown), Mark Willis, Valerie Anderson, (unknown), (unknown), Katharine Harding, Emma Tallantyre, Neil Robertson, (unknown)	1
8	Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease 2020 ·Journal of the Neurological Sciences ·Giordani Rodrigues dos Passos, Liene Elsone, Sebastian Luppe, Joanna Kitley, Silvia Messina, Pedro M. Rodríguez Cruz, Katharine Harding, Kerry Mutch, Maria Isabel Leite, Neil P. Robertson, Anu Jacob, Jacqueline Palace	10
9	Serum neurofilament-light concentration and real-world outcome in MS 2020 ·Journal of the Neurological Sciences ·Valerie Anderson, (unknown), Sam Loveless, Lucia Bianchi, Katharine Harding, (unknown), Fady Joseph, Gavin Giovannoni, Sharmilee Gnanapavan, Neil P. Robertson, Mónica Marta, Emma Tallantyre	15
10	179 Early real-world experience of ocrelizumab in MS 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Katharine Harding, Gillian Ingram, (unknown), Helen C. Owen, Fady Joseph, Owen Pearson	1
11	A contemporary study of mortality in the multiple sclerosis population of south east Wales 2018 ·Multiple Sclerosis and Related Disorders ·Katharine Harding, Valerie Anderson, Owain Williams, Mark Willis, (unknown), Emma Tallantyre, Fady Joseph, Mark Wardle, Trevor Pickersgill, Neil Robertson	9
12	How common is truly benign MS in a UK population? 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·Emma Tallantyre, (unknown), (unknown), (unknown), Fady Joseph, Valentina Tomassini, Trevor Pickersgill, Katharine Harding, Mark Willis, (unknown), Neil P. Robertson	20
13	Deep brain stimulation for dystonia 2016 ·Journal of Neurology ·Katharine Harding, Neil P. Robertson	2
14	A longitudinal model for disease progression was developed and applied to multiple sclerosis 2015 ·Journal of Clinical Epidemiology ·Michael Lawton, Kate Tilling, Neil Robertson, Helen Tremlett, Feng Zhu, Katharine Harding, Joël Oger, Yoav Ben‐Shlomo	15
15	The aetiology of acute neurological decline in multiple sclerosis: Experience from an open-access clinic 2014 ·Multiple Sclerosis Journal ·Emma Tallantyre, (unknown), Katharine Harding, Trevor Pickersgill, Neil P. Robertson	13
16	Modelling the natural history of primary progressive multiple sclerosis 2014 ·Journal of Neurology Neurosurgery & Psychiatry ·Katharine Harding, Mark Wardle, Perry Moore, Valentina Tomassini, Trevor Pickersgill, Yoav Ben‐Shlomo, Neil P. Robertson	31
17	Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis 2013 ·Journal of Neurology Neurosurgery & Psychiatry ·Laura Azzopardi, Sara Thompson, Katharine Harding, M. Cossburn, N. P. Robertson, Alastair Compston, Alasdair Coles, Joanne Jones	40
18	Demographic and clinical factors associated with changes in employment in multiple sclerosis 2013 ·Multiple Sclerosis Journal ·(unknown), Katharine Harding, (unknown), Trevor Pickersgill, Mark Wardle, Neil P. Robertson	114
19	Multiple sclerosis relapses and depression 2012 ·Journal of Psychosomatic Research ·(unknown), Claire Hirst, Katharine Harding, (unknown), Trevor Pickersgill, Neil P. Robertson	63
20	Long-term outcome of paediatric-onset multiple sclerosis: a population-based study 2012 ·Journal of Neurology Neurosurgery & Psychiatry ·Katharine Harding, (unknown), M. Cossburn, Gillian Ingram, Claire Hirst, Trevor Pickersgill, Johann te Water Naudé, Mark Wardle, Yoav Ben‐Shlomo, Neil P. Robertson	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact